Tech Company Financing Transactions
FluGen Funding Round
On 8/2/2017, FluGen received $5.5 million in financing from private investors.
Transaction Overview
Company Name
Announced On
8/2/2017
Transaction Type
Debt
Amount
$5,500,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 25 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
597 Science Dr.
Madison, WI 53711
USA
Madison, WI 53711
USA
Phone
Website
Email Address
Overview
FluGen is driving the development of a universal flu vaccine to advance human health.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Paul Radspinner
Chief Scientific Officer
Pamuk Bilsel
VP - R & D
Renee Herber
Browse more venture capital transactions:
Prev: 8/2/2017: Homology Medicines venture capital transaction
Next: 8/2/2017: Amplyx Pharmaceuticals venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs